- Abbott (ABT) and Sanofi partner to integrate to developing tools that combine the FreeStyle Libre technology with Sanofi′s insulin dosing information for future smartpens, insulin titration apps and cloud software. - The integration will enable both people with diabetes and their doctors to make better-informed treatment decisions around medication, nutrition, and lifestyle.Abbott (ABT) and Sanofi, today announced they are partnering to integrate glucose sensing and insulin delivery
Read More
Abbott
What’s the Difference: A Look at Consumer and Medical-Grade Wearables in Healthcare
Can both consumer and medical-grade wearables work together to fill healthcare’s care gaps? Dr. Sunil Kapur shares his insights.
What does Abbott’s Confirm Rx insertable cardiac monitor (ICM) and the latest Apple Watch have in common? The answer: more than you think, and perhaps not nearly enough. Today, consumer and medical-grade wearables may live in different markets, but they are aligning on a similar long-term objective—capturing critical data to improve outcomes.
“People want to
Read More
Abbott Integrates Insulin Dose Data with Novo Nordisk Insulin Pens
Abbott and Novo Nordisk today announced a non-exclusive partnership that will integrate insulin dose data from Novo Nordisk pre-filled and durable connected pens directly into the digital health tools compatible with the FreeStyle Libre system (FreeStyle LibreLinkii mobile app and LibreViewiii cloud-based system). The integration between Abbott and Novo Nordisk’s products will enable healthcare professionals, caregivers and people with diabetes to view glucose and insulin data together to help
Read More
